Value-Driven Clinical Data Review, Together

Clinical data review is no longer just a technical checkbox – it’s a strategic, cross-functional effort that can make or break the success of a clinical trial. When teams collaborate across functions, align on risk, and focus on value-driven review, the result is more reliable, coherent and compliant trial data.

In this session, we’ll explore how to move beyond traditional data cleaning by embracing a collaborative, risk-based approach. Learn how functional interdependencies – when properly understood and leveraged – can drive smarter, more efficient reviews.

We’ll also host a dynamic roundtable featuring voices from big pharma, tech and CROs, who will share real-world insights, challenges, and best practices for building effective, cross-functional data review strategies.

Whether you’re in data management, clinical operations, biostatistics, or a supporting function, this session will offer actionable strategies to foster collaboration and value-driven data review processes.

Ann Fleenor, Astellas Pharma

Ann Fleenor has over 19 years of experience in the pharmaceutical industry and clinical data management space. She has been involved in many facets of data management and therapeutic areas, eCOA, process development and improvement, and in the last nine years she has focused on risk-based quality management. She currently holds the position of Head, Central Monitoring at Astellas Pharma Global Development, leading and supporting the central monitoring risk management teams.

Neha Agarwal, ThermoFisher Scientific

Neha Agarwal is a Clinical Data Associate at ThermoFisher Scientific, where she supports data review and cleaning activities for global Phase I, II and III trials. Neha has a growing interested in data visualisation and cross-functional safety collaboration and is excited to share insights from recent project work with the wider clinical research community.